Chelsea Therapeutics Shareholder Alert: Former SEC Attorney Willie Briscoe & Powers Taylor LLP Investigate the Acquisition Pr...
21 Mai 2014 - 4:58PM
Business Wire
Former United States Securities and Exchange Commission attorney
Willie Briscoe and the securities litigation firm of Powers Taylor
LLP are investigating potential claims against the Board of
Directors of Chelsea Therapeutics (“Chelsea”) (NasdaqCM: CHTP)
concerning the proposed acquisition by H. Lundbeck. Under the
acquisition proposal, valued at approximately $658 million, Chelsea
shareholders will only receive $6.44 in cash per share owned and
contingent value rights worth up to $1.50. The total possible
consideration of $7.94 is well below at least one analyst’s
estimated value of $12 per share.
If you are an affected investor, and you want to learn more
about the investigation or if you have information that you believe
would be helpful to the determination of the fairness of the
proposed transaction, contact Willie Briscoe at The Briscoe Law
Firm, PLLC, (214) 239-4568, or via email at
WBriscoe@TheBriscoeLawFirm.com, or Patrick Powers at Powers Taylor
LLP, toll free (877) 728-9607, via e-mail at
shareholder@powerstaylor.com. There is no cost or fee to you.
The investigation centers on whether Chelsea’s Board of
Directors is acting in the shareholders’ best interests, whether
the board is properly negotiating a higher share price for the
shareholders, and whether the board has employed an adequate
process to review and act on the proposed transaction. Notably, at
least one analyst with Yahoo! Finance believes that the true
inherent value of the stock could be as high as $12 per share.
The Briscoe Law Firm, PLLC is a full service business litigation
and shareholder rights advocacy firm with more than 20 years of
experience in complex litigation and transactional matters.
Powers Taylor LLP is a boutique litigation law firm that handles
a variety of complex business litigation matters, including claims
of investor and stockholder fraud, shareholder oppression,
shareholder derivative suits, and security class actions.
The Briscoe Law Firm, PLLCWillie Briscoe,
214-239-4568WBriscoe@TheBriscoeLawFirm.comorPowers Taylor
LLPPatrick Powers, 877-728-9607shareholder@powerstaylor.com
Chelsea Therapeutics International, Ltd. (MM) (NASDAQ:CHTP)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
Chelsea Therapeutics International, Ltd. (MM) (NASDAQ:CHTP)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024
Real-Time news about Chelsea Therapeutics International, Ltd. (MM) (NASDAQ): 0 recent articles
Plus d'articles sur Chelsea Therapeutics International, Ltd. (MM)